Follow
Mutiara Saragih
Mutiara Saragih
Verified email at sci.ui.ac.id
Title
Cited by
Cited by
Year
Recent progress and challenges for drug-resistant tuberculosis treatment
F Stephanie, M Saragih, USF Tambunan
Pharmaceutics 13 (5), 592, 2021
252021
Identification of DNA methyltransferase-1 inhibitor for breast cancer therapy through computational fragment-based drug design
AH Alkaff, M Saragih, SN Imana, MAF Nasution, USF Tambunan
Molecules 26 (2), 375, 2021
82021
Epitope-Based Vaccine Design for Tuberculosis HIV Infection Through in silico Approach.
I Muttaqin, F Stephanie, M Saragih, FT US
Pakistan Journal of Biological Sciences: PJBS 24 (7), 765-772, 2021
62021
Screening of potential Northern African natural product compounds as Dengue Virus NS5 methyltransferase inhibitor: An in silico approach
F Stephanie, M Saragih, AH Alkaff, MAF Nasution, USF Tambunan
2019 IEEE 19th International Conference on Bioinformatics and Bioengineering …, 2019
62019
Identification of novel peptides targeting DNA methyltransferase 1 (DNMT-1) for breast cancer treatment
M Saragih, F Stephanie, AH Alkaff, USF Tambunan
Revista Brasileira de Farmacognosia 30, 641-651, 2020
52020
Discovery of novel DNMT-1 inhibitor by fragment-based drug design as a potential breast cancer treatment
USF Tambunan, M Saragih, AH Alkaff, AH Natalia, IN Istiqomah
GEOMATE Journal 17 (62), 41-46, 2019
32019
Role of immunoinformatics in accelerating epitope-based vaccine development against Dengue virus
AH Alkaff, M Saragih, MA Fardiansyah, USF Tambunan
The Open Biochemistry Journal 14 (1), 2020
22020
Identification novel peptides conjugated to hiv1 tat peptide to inhibit ebola virus entry by targeting niemann pick C1 protein
M Saragih, F Stephanie, AH Alkaff, USF Tambunan
2019 IEEE 19th International Conference on Bioinformatics and Bioengineering …, 2019
22019
Utilization of flavonoid compounds as HER2 tyrosine kinase inhibitor in breast cancer using fragment-based drug design
VJ Fleming, M Saragih, USF Tambunan
Key Engineering Materials 840, 230-236, 2020
12020
In silico Antivirus Repurposing and its Modification to Organoselenium Compounds as SARS-CoV-2 Spike Inhibitors
M Huang, M Saragih, USF Tambunan
Pakistan journal of biological sciences: PJBS 26 (2), 81-90, 2023
2023
Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription
F Stephanie, M Saragih, USF Tambunan, TJ Siahaan
Life 12 (9), 1333, 2022
2022
Identification of natural product compounds as NS5 RDRP inhibitor for dengue virus serotype 1-4 through in silico analysis
HH Putra, M Saragih, Y Yulianti, USF Tambunan
AIP Conference Proceedings 2237 (1), 2020
2020
Fragment-Based drug design to inhibit DNA Methyltransferase 1 (DNMT1) for breast cancer therapy
USF Tambunan, AH Natalia, AH Alkaff, M Saragih, IN Istiqomah
GEOMATE Journal 17 (62), 35-40, 2019
2019
Discovery of biogenic-based compound as potential heat-shock protein 90 inhibitor through fragment-based drug design
HH Putra, M Saragih, MAN Fardiansyah, R Bakri, USF Tambunan
IOP Conference Series: Materials Science and Engineering 509 (1), 012081, 2019
2019
Virtual screening of natural products as an inhibitor of DNA methyltransferase 1 enzyme for breast cancer disease
IN Istiqomah, AH Alkaff, M Saragih, AH Natalia, USF Tambunan
IOP Conference Series: Materials Science and Engineering 509 (1), 012052, 2019
2019
Inhibition of Primed Ebola Virus Glycoprotein by Peptide Compound Conjugated to HIV-1 Tat Peptide Through a Virtual Screening Approach
AH Alkaff, M Saragih, MAF Nasution, USF Tambunan
International Meeting on Computational Intelligence Methods for …, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–16